EXL logo

Elixinol Wellness Stock Price

Symbol: ASX:EXLMarket Cap: AU$3.7mCategory: Household

EXL Share Price Performance

AU$0.016
-0.02 (-50.00%)
AU$0.016
-0.02 (-50.00%)
Price AU$0.016

EXL Community Narratives

There are no narratives available yet.

Recent EXL News & Updates

No updates

Elixinol Wellness Limited Key Details

AU$15.0m

Revenue

AU$9.6m

Cost of Revenue

AU$5.4m

Gross Profit

AU$7.1m

Other Expenses

-AU$1.7m

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.0075
Gross Margin
35.82%
Net Profit Margin
-11.51%
Debt/Equity Ratio
16.5%

Elixinol Wellness Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About EXL

Founded
2017
Employees
n/a
CEO
Natalie Butler
WebsiteView website
www.elixinolwellness.com

Elixinol Wellness Limited, a holding company, provides healthy products in Australia, the Americas, and internationally. The company provides human nutrition, human wellness, pet wellness, and superfood ingredients under Hemp Foods Australia, Mt Elephant, The Healthy Chef, Soul Foods, Ananda Equine, and Field Day brands. It distributed through grocery, wholesale, and e-commerce channels for white label customers, as well as food, beverage, and beauty manufacturers. In addition, the company engages in the development, sourcing, marketing, and distribution of hemp-derived CBD products, including skincare. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in South Melbourne, Australia.

Australian Market Performance

  • 7 Days: 1.2%
  • 3 Months: 7.7%
  • 1 Year: 15.0%
  • Year to Date: 7.3%
The market is up 1.2% over the last week, with the Materials sector leading the way, up 4.0%. The market is up 15% over the last 12 months. Earnings are forecast to grow by 11% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading